【レポートの概要（一部）】
Table of Content
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Market Snapshot
Chapter 4. Market Variables, Trends & Scope
4.1. Market segmentation & scope
4.2. Cardiac biomarkers: Market dynamics
4.2.1. Market driver analysis
4.2.2. Market restraint analysis
4.3. Penetration & growth prospect mapping
4.4. Cardiac Biomarkers – SWOT Analysis, By Factor (political & legal, economic and technological)
4.5. Industry Analysis – Porter’s
4.6. Cardiac Biomarkers Market: Company Market Share Analysis, 2015
Chapter 5. Market Categorization 1: Cardiac Biomarkers Type Estimates & Trend Analysis
5.1. Cardiac Biomarkers Market: Type Movement Analysis
5.2. Troponin
5.2.1. Market estimates and forecasts, 2013 – 2024 (USD Million)
5.3. CK-MB
5.3.1. Market estimates and forecasts, 2013 – 2024 (USD Million)
5.4. Natriuretic Peptides (BNP and NT-proBNP)
5.4.1. Market estimates and forecasts, 2013 – 2024 (USD Million)
5.5. Myoglobin
5.5.1. Market estimates and forecasts, 2013 – 2024 (USD Million)
5.6. Others
5.6.1. Market estimates and forecasts, 2013 – 2024 (USD Million)
Chapter 6. Market Categorization 2: Cardiac Biomarkers Application Estimates & Trend Analysis
6.1. Cardiac Biomarkers Market: Application Movement Analysis
6.2. Acute Myocardial Infarction (AMI)
6.2.1. Market estimates and forecasts, 2013 – 2024 (USD Million)
6.3. Congestive Heart Failure (CHF)
6.3.1. Market estimates and forecasts, 2013 – 2024 (USD Million)
6.4. Acute Coronary Syndrome (ACS)
6.4.1. Market estimates and forecasts, 2013 – 2024 (USD Million)
6.5. Others
6.5.1. Market estimates and forecasts, 2013 – 2024 (USD Million)
Chapter 7. Market Categorization 3: Cardiac Biomarkers End-use Estimates & Trend Analysis
7.1. Cardiac Biomarkers Market: End-use Movement Analysis
7.2. Laboratory Testing
7.2.1. Market estimates and forecasts, 2013 – 2024 (USD Million)
7.3. Point of Care Testing
7.3.1. Market estimates and forecasts, 2013 – 2024 (USD Million)
Chapter 8. Cardiac biomarkers: Regional Estimates & Trend Analysis, by Type, Application, & End-use
8.1. Cardiac biomarkers Market Share (%) Analysis, by Region, 2016 & 2024
8.2. North America
8.2.1. U.S.
8.2.1.1. U.S. Cardiac biomarkers market, by type, 2013 – 2024 (USD Million)
8.2.1.2. U.S. Cardiac biomarkers market, by application, 2013 – 2024 (USD Million)
8.2.1.3. U.S. Cardiac biomarkers market, by end-use, 2013 – 2024 (USD Million)
8.2.2. Canada
8.2.2.1. Canada Cardiac biomarkers market, by type, 2013 – 2024 (USD Million)
8.2.2.2. Canada Cardiac biomarkers market, by application, 2013 – 2024 (USD Million)
8.2.2.3. Canada Cardiac biomarkers market, by end-use, 2013 – 2024 (USD Million)
8.3. Europe
8.3.1. Germany
8.3.1.1. Germany Cardiac biomarkers market, by type, 2013 – 2024 (USD Million)
8.3.1.2. Germany Cardiac biomarkers market, by application, 2013 – 2024 (USD Million)
8.3.1.3. Germany Cardiac biomarkers market, by end-use, 2013 – 2024 (USD Million)
8.3.2. UK
8.3.2.1. UK Cardiac biomarkers market, by type, 2013 – 2024 (USD Million)
8.3.2.2. UK Cardiac biomarkers market, by application, 2013 – 2024 (USD Million)
8.3.2.3. UK Cardiac biomarkers market, by end-use, 2013 – 2024 (USD Million)
8.4. Asia Pacific
8.4.1. China
8.4.1.1. China Cardiac biomarkers market, by type, 2013 – 2024 (USD Million)
8.4.1.2. China Cardiac biomarkers market, by application, 2013 – 2024 (USD Million)
8.4.1.3. China Cardiac biomarkers market, by end-use, 2013 – 2024 (USD Million)
8.4.2. India
8.4.2.1. India Cardiac biomarkers market, by type, 2013 – 2024 (USD Million)
8.4.2.2. India Cardiac biomarkers market, by application, 2013 – 2024 (USD Million)
8.4.2.3. India Cardiac biomarkers market, by end-use, 2013 – 2024 (USD Million)
8.5. Latin America
8.5.1. Brazil
8.5.1.1. Brazil cardiac biomarkers market, by type, 2013 – 2024 (USD Million)
8.5.1.2. Brazil cardiac biomarkers market, by application, 2013 – 2024 (USD Million)
8.5.1.3. Brazil cardiac biomarkers market, by end-use, 2013 – 2024 (USD Million)
8.5.2. Mexico
8.5.2.1. Mexico cardiac biomarkers market, by type, 2013 – 2024 (USD Million)
8.5.2.2. Mexico cardiac biomarkers market, by application, 2013 – 2024 (USD Million)
8.5.2.3. Mexico cardiac biomarkers market, by end-use, 2013 – 2024 (USD Million)
8.6. Middle East Africa
8.6.1. South Africa
8.6.1.1. South Africa cardiac biomarkers market, by type, 2013 – 2024 (USD Million)
8.6.1.2. South Africa cardiac biomarkers market, by application, 2013 – 2024 (USD Million)
8.6.1.3. South Africa cardiac biomarkers market, by end-use, 2013 – 2024 (USD Million)
8.6.2. Middle East
8.6.2.1. Middle East cardiac biomarkers market, by type, 2013 – 2024 (USD Million)
8.6.2.2. Middle East cardiac biomarkers market, by application, 2013 – 2024 (USD Million)
8.6.2.3. Middle East cardiac biomarkers market, by end-use, 2013 – 2024 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company Profiles
9.1.1. Abbott Laboratories
9.1.1.1. Company Overview
9.1.1.2. Financial Performance
9.1.1.3. Product Benchmarking
9.1.1.4. Strategic Initiatives
9.1.2. Alere, Inc.
9.1.2.1. Company Overview
9.1.2.2. Financial Performance
9.1.2.3. Product Benchmarking
9.1.2.4. Strategic Initiatives
9.1.3. Siemens Healthcare GmbH
9.1.3.1. Company Overview
9.1.3.2. Financial Performance
9.1.3.3. Product Benchmarking
9.1.3.4. Strategic Initiatives
9.1.4. Roche Diagnostics Corporation
9.1.4.1. Company Overview
9.1.4.2. Financial Performance
9.1.4.3. Product Benchmarking
9.1.4.4. Strategic Initiatives
9.1.5. Beckman Coulter, Inc.
9.1.5.1. Company Overview
9.1.5.2. Financial Performance
9.1.5.3. Product Benchmarking
9.1.5.4. Strategic Initiatives
9.1.6. Becton, Dickinson &Co.
9.1.6.1. Company Overview
9.1.6.2. Financial Performance
9.1.6.3. Product Benchmarking
9.1.6.4. Strategic Initiatives
9.1.7. Thermo Fisher Scientific, Inc.
9.1.7.1. Company Overview
9.1.7.2. Financial Performance
9.1.7.3. Product Benchmarking
9.1.7.4. Strategic Initiatives
9.1.8. bioMérieux SA
9.1.8.1. Company Overview
9.1.8.2. Financial Performance
9.1.8.3. Product Benchmarking
9.1.8.4. Strategic Initiatives
9.1.9. Bio-Rad Laboratories, Inc.
9.1.9.1. Company Overview
9.1.9.2. Financial Performance
9.1.9.3. Product Benchmarking
9.1.9.4. Strategic Initiatives
9.1.10. BG Medicines
9.1.10.1. Company Overview
9.1.10.2. Financial Performance
9.1.10.3. Product Benchmarking
9.1.10.4. Strategic Initiatives
【レポート販売概要】
■ タイトル：心臓バイオマーカーの世界市場分析：タイプ別（トロンポニン、クレアチンキナーゼ-MB（CK-MB）、ナトリウム利尿ペプチド-B型ナトリウム利尿ペプチド（BNP）･N末端プロb型ナトリウム利尿ペプチド（NT-proBNP）、ミオグロビン、虚血修飾アルブミン（IMA）、心臓型脂肪酸結合タンパク質（H-FABP）、LDHアイソザイム）、用途別（急性冠動脈症候群、心筋梗塞、うっ血性心不全、心筋症、虚血、心筋炎、心房細動）、エンドユーザー別、地域別、セグメント予測■ 英文：Cardiac Biomarkers Market By Type (Troponin, Creatine kinase - MB (CK-MB), Natriuretic peptides - B-type Natriuretic Peptide (BNP) & N-terminal pro b-type Natriuretic peptide (NT-proBNP), Myoglobin, Ischemia Modified Albumin (IMA), Heart-type Fatty Acid Binding Protein (H-FABP), LDH isoenzymes), By Application (Acute Coronary Syndrome, Myocardial infarction, Congestive heart failure, Cardiomyopathy, Ischemia, Myocarditis, Atrial fibrillation), By End Use, By Region And Segment Forecasts to 2024
■ 発行日：2016年9月5日
■ 調査会社：Grand View Research
■ 商品コード：GVIEW707163
■ 調査対象地域：グローバル
- GFRP（ガラス繊維強化プラスチック）複合材の世界市場予測：ポリエステル、ビニルエステル、ポリウレタン、エポキシThe global Glass Fiber Reinforced Plastics (GFRP) composites market is projected to grow from USD 44.10 Billion in 2016 to USD 60.33 Billion by 2021, at a CAGR of 6.47% during the forecast period. The GFRP composites market is growing due to the high demand from the wind energy & other emerging application industries such as electrical & electronics, and transportation. GFRP composites are preferr …
- 世界のパワーディスクリート市場動向（2012-2016）TechNavio's analysts forecast the Global Power Discrete market to grow at a CAGR of 10.9 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for power discrete devices from the renewable energy segment. The Global Power Discrete market has also been witnessing the increasing focus on power discrete semiconductor chip optimization. H …
- 統合失調症に伴う認知機能障害(CIAS)：グローバル臨床試験レビュー（2014年上半期）Cognitive Impairment Associated With Schizophrenia (CIAS) Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Cognitive Impairment Associated With Schizophrenia (CIAS) Global Clinical Trials Review, H1, 2014" provides data on the Cognitive Impairment Associated With Schizophrenia (CIAS) clinical trial scenario. This report provides elemental information and data re …
- August Refined Products ForecastAugust Refined Products Forecast Summary Gasoline demand is surprisingly strong in our latest forecast, due more to data revisions than to changes in consumer behavior. Official data often change like that – without warning and quite unexpectedly, making the analyst’s job fraught with peril. Before the revisions, we forecast developed nation gasoline demand reliably below five-year averages, but f …
- 世界の高圧直流(HVDC)送電市場：変換所・送電線への支出動向Visiongain calculates that the global High Voltage Direct Current (HVDC) transmission market will be worth $25.79bn in 2014. From a global perspective, capital expenditure on HVDC transmission will enjoy stability over the next 10 years. Regionally, spending is much more volatile; different trends, regulatory environments, stages of electrical grid development, political priorities and distributio …
- 自動調剤機の世界市場2015-2019About Automated Dispensing Machines An automated dispensing machine is a computerized dispensing and drug storage device, which is used by healthcare facilities such as hospitals and pharmacies. These machines are located at the POC such as the ICU, the ward, and ED. The automated dispensing system is integrated with the main medication information system and functions as a decentralized distribut …
- 2014年戦略提言：世界の潜血検査市場The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technolog …
- Babcock & Wilcox Power Generation Group Acquires MEGTEC Systems：M&Aディール分析Babcock & Wilcox Power Generation Group Acquires MEGTEC Systems - Deal Analysis from GlobalData Summary On June 23, 2014, Babcock & Wilcox Power Generation Group (B&W PGG), an equipment manufacturing company, acquired MEGTEC Systems (MEGTEC), an environmental solutions provider, for a purchase consideration of $155m. Following the acquisition, MEGTEC will operate as B&W MEGTEC, a wholly owned subs …
- 世界の人工瘻ケア（ストーマケア）用品市場（2014-2018）About Ostomy Care Accessories Ostomy refers to a surgically made opening (stoma) in the body for the excretion of waste products such as stools, mucus, and urine from the intestines or urinary bladder externally. An ostomy can be a temporary or permanent procedure, depending on the type of condition and the needs of the patient. There are three types of ostomy: colostomy, ileostomy, and urostomy. …
- 尿素13Cの世界市場2015Urea-13C (CAS 58069-82-2) Market Research Report 2015 aims at providing comprehensive data on Urea-13C market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes Urea-13C description, covers its application areas, manufacturing methods, patterns. It captures Urea-13C market trends, pays close attention to Urea-13C manufacturers and names suppliers. Besides …
- 洗面化粧台の世界市場分析：材料別（石、セラミック、ガラス、木、金属）、用途別（住居用、非住居用）セグメント予測、-2020The Global Bathroom Vanities Market is expected to reach USD 8.40 billion by 2020, according to a new study by Grand View Research, Inc. Increasing reconstruction and remodeling activities owing to changing consumer preferences is anticipated to spur market growth over the forecast period. Growing demand for functional bathrooms may promote the installation of specialized countertops which incorpo …
- 磁気共鳴画像法（MRI）装置の世界市場予測（～2021）The global MRI systems market is projected to reach USD 7.19 Billion by 2021 from USD 5.61 Billion in 2016, at a CAGR of 5.1% from 2016 to 2021. The MRI systems market is broadly segmented by architecture, field strength, application, and region. The major factors fuelling market growth are the rising geriatric population; advancements in MRI techniques such as the development of superconducting ( …
- 酪酸の世界市場：用途、種類（合成酪酸、再生可能酪酸）、地域別分析The report covers the global butyric acid market and further segments the market on the basis of type, application, and region. The market data for these types is given with respect to volume (kilotons) and value (USD million). The global market value of butyric acid is estimated to be USD 124.6 million in 2015 and is projected to grow at a CAGR of about 15.1% between 2015 and 2020 to reach USD 28 …
- 世界のサーマルイメージング（熱画像）市場動向（2012-2016）TechNavio's analysts forecast the Global Thermal Imaging market to grow at a CAGR of 20.5 percent over the period 2012-2016. One of the key factors contributing to this market growth is the need for predictive maintenance of electrical systems. The Global Thermal Imaging market has also been witnessing the emergence of the incorporation of communication interfaces. However, the need for increased …
- コンテナ・フリートの世界市場2017-2021：ドライコンテナ、リーファーコンテナ、タンクコンテナShipping containers are large containers that can withstand handling and transportation of goods varying from dry goods to hazardous liquids. Almost 80% of the global merchandize trade is seaborne. Of this, the container fleet market holds the largest market share, accounting for more than 50% of the market and more than one third of the global trade. One of the major reasons for such a high marke …
